We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

93 hedge funds and large institutions have $133M invested in Kronos Bio in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 21

3% less funds holding

Funds holding: 96 → 93 (-3)

3.86% less ownership

Funds ownership: 68.9% → 65.04% (-3.9%)

53% less capital invested

Capital invested by funds: $282M → $133M (-$149M)

Holders
93
Holders Change
-3
Holders Change %
-3.13%
% of All Funds
1.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
21
Increased
31
Reduced
20
Closed
21
Calls
$535K
Puts
–
Net Calls
+$535K
Net Calls Change
-$477K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$2.77M
2
PFMU
Privium Fund Management (UK)
United Kingdom
+$1.95M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.33M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.3M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$1.29M

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$22.3M
2
State Street
State Street
Massachusetts
-$5.47M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$3.59M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.21M
5
CC
Casdin Capital
New York
-$2.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
26
EcoR1 Capital
California
$1.19M – – –
CIA
27
Choate Investment Advisors
Massachusetts
$1.12M – – –
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$1.05M +$1.3M +287,892 New
Federated Hermes
29
Federated Hermes
Pennsylvania
$1.04M +$1.29M +285,465 New
Millennium Management
30
Millennium Management
New York
$1.03M +$1.15M +253,944 +869%
Charles Schwab
31
Charles Schwab
California
$1.03M +$48.6K +10,712 +4%
N
32
Nuveen
North Carolina
$835K +$286K +63,064 +38%
Morgan Stanley
33
Morgan Stanley
New York
$778K +$26.3K +5,807 +3%
Two Sigma Advisers
34
Two Sigma Advisers
New York
$722K +$838K +184,800 +1,369%
OMC
35
Oasis Management Company
Cayman Islands
$714K +$889K +196,078 New
HF
36
HRT Financial
New York
$626K +$337K +74,387 +76%
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$612K +$230K +50,800 +43%
SG Americas Securities
38
SG Americas Securities
New York
$539K +$96.9K +21,369 +17%
Acadian Asset Management
39
Acadian Asset Management
Massachusetts
$536K +$652K +143,744 +4,030%
Deutsche Bank
40
Deutsche Bank
Germany
$520K +$95.4K +21,051 +17%
NM
41
Newtyn Management
New York
$461K +$574K +126,623 New
CC
42
Casdin Capital
New York
$451K -$2.08M -459,597 -79%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$445K -$50.5K -11,150 -8%
Ameriprise
44
Ameriprise
Minnesota
$360K +$45.8K +10,108 +11%
GCM
45
Graham Capital Management
Connecticut
$333K +$415K +91,582 New
GCP
46
GSA Capital Partners
United Kingdom
$316K +$196K +43,284 +99%
SB
47
Samsara BioCapital
California
$284K – – –
E
48
Ergoteles
New York
$277K +$200K +44,100 +138%
OQS
49
Occudo Quantitative Strategies
Florida
$270K +$336K +74,161 New
Invesco
50
Invesco
Georgia
$243K +$40.9K +9,023 +16%
1
2
3 4 5

KRON Hedge Fund Activity: Q2 2022 in Review

93 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q2 2022, worth a combined $133M — down 53% from $282M a quarter earlier.

Fund positioning in KRON was balanced in Q2 2022: 21 funds opened new positions, 21 closed out, 31 added to existing stakes and 20 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $2.77M. The largest seller was Capital World Investors, exiting entirely with an estimated $22.3M sold.

  • 93 institutional investors held Kronos Bio (KRON) as of Q2 2022, down from 96 in Q1 2022.
  • Funds reported $133M of Kronos Bio stock for Q2 2022, down 53% quarter-over-quarter.
  • 21 funds opened new Kronos Bio positions in Q2 2022 and 21 closed out, a net change of 0 holders.
  • The largest Kronos Bio buyer in Q2 2022 was Renaissance Technologies, an estimated $2.77M added.
  • The largest Kronos Bio seller in Q2 2022 was Capital World Investors, an estimated $22.3M sold.

Based on aggregated 13F filings for Q2 2022.